ストックスクリーナーアプリを入手
0.9446
7.46%
0.0656
アフターアワーズ：
.96
0.0154
+1.63%
前日終値:
$0.879
開ける：
$0.8717
24時間の取引高:
317.51K
Relative Volume:
0.72
時価総額：
$14.24M
収益：
-
当期純損益:
$-11.90M
株価収益率:
-0.00459
EPS:
-206.0125
ネットキャッシュフロー:
$-12.75M
1週間 パフォーマンス:
-1.40%
1か月 パフォーマンス:
-5.04%
6か月 パフォーマンス:
-0.93%
1年 パフォーマンス:
+434.58%
1日の値動き範囲:
$0.8717
$0.9623
1週間の範囲:
$0.84
$0.9623
52週間の値動き範囲:
$0.1131
$3.95
Allarity Therapeutics Inc Stock (ALLR) Company Profile
名前
Allarity Therapeutics Inc
セクター
電話
401-426-4664
住所
24 SCHOOL ST., 2ND FLOOR, BOSTON
ALLR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALLR
Allarity Therapeutics Inc
|
0.9446 | 13.72M | 0 | -11.90M | -12.75M | -206.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-28 | 開始されました | Ascendiant Capital Markets | Buy |
Allarity Therapeutics Inc (ALLR) 最新ニュース
How to forecast Allarity Therapeutics Inc. trends using time seriesTrade Volume Report & Weekly Return Optimization Alerts - Newser
Allarity Therapeutics Delays 10-Q Filing - MSN
Stock Market Today: Nasdaq 100 Futures Slip— Palo Alto, XP, Allarity Earnings In Focus (UPDATED) - Benzinga
What machine learning models say about Allarity Therapeutics Inc.Earnings Risk Report & Verified Swing Trading Watchlists - Newser
Palo Alto Networks, Fabrinet And 3 Stocks To Watch Heading Into Monday - Benzinga
Published on: 2025-08-18 10:13:44 - beatles.ru
Volatility clustering patterns for Allarity Therapeutics Inc.July 2025 Update & Safe Capital Allocation Plans - Newser
Why Allarity Therapeutics Inc. stock attracts strong analyst attentionPortfolio Risk Summary & Reliable Price Action Trade Plans - Newser
How to use Fibonacci retracement on Allarity Therapeutics Inc.July 2025 PostEarnings & Free Real-Time Volume Trigger Notifications - Newser
Is Allarity Therapeutics Inc. forming a reversal patternWeekly Loss Report & Fast Exit and Entry Trade Guides - Newser
Momentum divergence signals in Allarity Therapeutics Inc. chart2025 Support & Resistance & Fast Gaining Stock Reports - Newser
Allarity Therapeutics Inc. stock volume spike explainedEarnings Growth Report & Free Community Consensus Stock Picks - Newser
Top chart patterns to watch in Allarity Therapeutics Inc.Weekly Trade Review & Capital Efficient Trading Techniques - Newser
Statistical indicators supporting Allarity Therapeutics Inc.’s strengthJuly 2025 Market Mood & Fast Exit and Entry Strategy Plans - Newser
Advanced analytics toolkit walkthrough for Allarity Therapeutics Inc.Quarterly Market Summary & Reliable Breakout Forecasts - Newser
Will Allarity Therapeutics Inc. stock benefit from interest rate changesCPI Data & Stock Portfolio Risk Management - Newser
What makes Allarity Therapeutics Inc. stock price move sharplyInflation Watch & Accurate Entry and Exit Point Alerts - kangso.co.kr
Chart based analysis of Allarity Therapeutics Inc. trends2025 Bull vs Bear & Daily Growth Stock Investment Tips - Newser
Allarity Therapeutics Provides Second Quarter 2025 Update, - GlobeNewswire
Order flow analysis tools used on Allarity Therapeutics Inc.2025 Trading Recap & Technical Entry and Exit Alerts - Newser
Allarity Therapeutics Delays Q2 Earnings Report Due to Audit Review - AInvest
How Allarity Therapeutics Inc. stock performs during market volatilityEarnings Growth Report & Precise Swing Trade Entry Alerts - Newser
Short interest data insights for Allarity Therapeutics Inc.Quarterly Profit Review & Low Risk High Win Rate Stock Picks - Newser
Momentum Indicator Shows Bearish Divergence in Allarity Therapeutics Inc.Bear Alert & Stepwise Trade Signal Implementation - beatles.ru
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP - Bluefield Daily Telegraph
Allarity Therapeutics, Inc. SEC 10-Q Report - TradingView
First Patients Dosed: Allarity's Dual-Action Cancer Drug Stenoparib Enters Critical Phase 2 Trial - Stock Titan
Price action breakdown for Allarity Therapeutics Inc.Weekly Trend Recap & Low Risk Profit Maximizing Plans - Newser
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships - Business Upturn
Will Allarity Therapeutics Inc. bounce back from current support2025 Historical Comparison & Entry Point Strategy Guides - Newser
Chart overlay techniques for tracking Allarity Therapeutics Inc.New Guidance & Safe Entry Momentum Tips - Newser
Identifying reversal signals in Allarity Therapeutics Inc.Market Risk Analysis & Weekly High Potential Alerts - Newser
Allarity Therapeutics Inc. Included in Top Momentum ScanWeekly Trading Summary & Reliable Price Breakout Signals - newsyoung.net
Earnings visualization tools for Allarity Therapeutics Inc.Weekly Trade Analysis & Consistent Income Trade Ideas - Newser
Is Allarity Therapeutics Inc. the Top Chart Pick This WeekJuly 2025 Chart Watch & Target Return Focused Stock Picks - newsyoung.net
Analyzing Allarity Therapeutics Inc. with multi timeframe chartsPortfolio Profit Report & Stock Market Timing Techniques - Newser
Identifying reversal signals in Allarity Therapeutics Inc. [July 2025 Intraday Action]AI Powered Market Entry Ideas - Newser
What MACD signals say about Allarity Therapeutics Inc.Free Early Entry Picks Before News Breakout - Newser
Strategies to average down on Allarity Therapeutics Inc.Weekly Chart Watchlist with Trade Guidance - Newser
Allarity Therapeutics Inc (ALLR) 財務データ
収益
当期純利益
現金流量
EPS
0.94%
1.72%
大文字化:
|
ボリューム (24 時間):